CLINICAL_TRIALS
research
· 2026-01-05
Clinical Trial Update: Cross-sectional Characterization of Idiopathic Bronchiectasis
Summary
NHLBI-sponsored cross-sectional study titled 'Cross-sectional Characterization of Idiopathic Bronchiectasis' has completed. The study characterizes patients wit…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Infection, Bronchial Diseases | Status: COMPLETED